Obamiro KO - Search Results

1

Correction: Anticoagulation Knowledge Tool (AKT): Further evidence of validity in the Italian population.

Magon A, Arrigoni C, Roveda T, Grimoldi P, Dellafiore F, Moia M, Obamiro KO, Caruso R. Magon A, et al. Among authors: obamiro ko. PLoS One. 2018 Nov 15;13(11):e0204534. doi: 10.1371/journal.pone.0204534. eCollection 2018. PLoS One. 2018. PMID: 30439943 Free PMC article.

2

Anticoagulation Knowledge Tool (AKT): Further evidence of validity in the Italian population.

Magon A, Arrigoni C, Roveda T, Grimoldi P, Dellafiore F, Moia M, Obamiro KO, Caruso R. Magon A, et al. Among authors: obamiro ko. PLoS One. 2018 Aug 14;13(8):e0201476. doi: 10.1371/journal.pone.0201476. eCollection 2018. PLoS One. 2018. PMID: 30106955 Free PMC article.

3

Development and Validation of an Oral Anticoagulation Knowledge Tool (AKT).

Obamiro KO, Chalmers L, Bereznicki LR. Obamiro KO, et al. PLoS One. 2016 Jun 28;11(6):e0158071. doi: 10.1371/journal.pone.0158071. eCollection 2016. PLoS One. 2016. PMID: 27351746 Free PMC article.

4

Anticoagulation knowledge in patients with atrial fibrillation: An Australian survey.

Obamiro KO, Chalmers L, Lee K, Bereznicki BJ, Bereznicki LRE. Obamiro KO, et al. Int J Clin Pract. 2018 Mar;72(3):e13072. doi: 10.1111/ijcp.13072. Epub 2018 Feb 19. Int J Clin Pract. 2018. PMID: 29457323

5

The relationship between knowledge, health literacy, and adherence among patients taking oral anticoagulants for stroke thromboprophylaxis in atrial fibrillation.

Rolls CA, Obamiro KO, Chalmers L, Bereznicki LRE. Rolls CA, et al. Among authors: obamiro ko. Cardiovasc Ther. 2017 Dec;35(6). doi: 10.1111/1755-5922.12304. Epub 2017 Sep 25. Cardiovasc Ther. 2017. PMID: 28869793 Free article.

6

Information overload in patients with atrial fibrillation: Can the cancer information overload (CIO) scale be used?

Obamiro K, Lee K. Obamiro K, et al. Patient Educ Couns. 2019 Mar;102(3):550-554. doi: 10.1016/j.pec.2018.10.005. Epub 2018 Oct 3. Patient Educ Couns. 2019. PMID: 30314829

7

Adherence to Oral Anticoagulants in Atrial Fibrillation: An Australian Survey.

Obamiro KO, Chalmers L, Lee K, Bereznicki BJ, Bereznicki LR. Obamiro KO, et al. J Cardiovasc Pharmacol Ther. 2018 Jul;23(4):337-343. doi: 10.1177/1074248418770201. Epub 2018 Apr 15. J Cardiovasc Pharmacol Ther. 2018. PMID: 29658327

8

A Summary of the Literature Evaluating Adherence and Persistence with Oral Anticoagulants in Atrial Fibrillation.

Obamiro KO, Chalmers L, Bereznicki LR. Obamiro KO, et al. Am J Cardiovasc Drugs. 2016 Oct;16(5):349-63. doi: 10.1007/s40256-016-0171-6. Am J Cardiovasc Drugs. 2016. PMID: 27262433 Review.

9

Public Awareness of Bowel Cancer Risk Factors, Symptoms and Screening in Tasmania, Australia: A Cross-Sectional Study.

Lee SM, Versace VL, Obamiro K. Lee SM, et al. Int J Environ Res Public Health. 2022 Jan 28;19(3):1497. doi: 10.3390/ijerph19031497. Int J Environ Res Public Health. 2022. PMID: 35162541 Free PMC article.

10

Assessment of quality and readability of internet-based health information related to commonly prescribed angiotensin receptor blockers.

Oloidi A, Nduaguba SO, Obamiro K. Oloidi A, et al. Pan Afr Med J. 2020 Mar 11;35:70. doi: 10.11604/pamj.2020.35.70.18237. eCollection 2020. Pan Afr Med J. 2020. PMID: 32537073 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters